[Antibacterial effect of two sulfonamide compoundds in acute experimental E. coli-pyelonephritis].
D000208:Acute Disease; D000818:Animals; D001437:Bacteriuria / Q000188:drug therapy; D001835:Body Weight / Q000187:drug effects; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use*; D007668:Kidney / Q000382:microbiology; D009929:Organ Size; D011704:Pyelonephritis / Q000188:drug therapy*; D051381:Rats; D013431:Sulfates / Q000627:therapeutic use; D013432:Sulfathiazoles / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
D005839:Gentamicins; D013431:Sulfates; D013432:Sulfathiazoles; D013449:Sulfonamides
Antibakterielle Wirkung von zqei Sulfonamid-Präparaten bei akuter experimenteller E. Coli-Pyelonephritis.